Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis

• Váldodahkkit: Dan Chisholm (Dahkki), Oye Gureje (Dahkki), Sandra Saldivia (Dahkki), Marcelo Villalón Calderón (Dahkki), Rajitha Wickremasinghe (Dahkki), Nalaka Mendis (Dahkki), Jose-Luis (Dahkki), Shekhar Saxena (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: The World Health Organization, 2008-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

OBJECTIVE: Schizophrenia is a highly disabling disease and is costly to treat. We set out to establish what are the most cost-effective interventions applicable to developing regions and countries. METHODS: Analysis was undertaken at the level of three WHO subregions spanning the Americas, Africa an...